Are you Dr. Kamat?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 65 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
6550 Fannin Street
Suite 901
Houston, TX 77030Phone+1 713-441-1026Fax+1 713-799-9586- Is this information wrong?
Summary
- Dr. Aparna (Wahekar) Kamat, MD is an obstetrician/gynecologist in Houston, Texas. She is currently licensed to practice medicine in Texas. She is affiliated with Houston Methodist Hospital, Houston Methodist Sugar Land Hospital, and Houston Methodist West Hospital.
Education & Training
University of Texas M D Anderson Cancer CenterFellowship, Gynecologic Oncology, 2004 - 2008
West Virginia UniversityResidency, Obstetrics and Gynecology, 1997 - 2001
Seth G.S. Medical CollegeClass of 1994
Certifications & Licensure
TX State Medical License 2002 - 2025- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- Top Doctors:SE Texas Castle Connolly, 2013
- Fellow (FACOG) American Congress of Obstetricians and Gynecologists
Clinical Trials
- Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer Start of enrollment: 2007 Dec 06
- Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Start of enrollment: 2012 Jun 18
- Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II Endometrial Cancer Start of enrollment: 2009 Mar 23
- Join now to see all
Publications & Presentations
PubMed
- Macrophage Checkpoint Nanoimmunotherapy Has the Potential to Reduce Malignant Progression in BioengineeredModels of Ovarian Cancer.Sabrina N VandenHeuvel, Eric Chau, Arpita Mohapatra, Sameera Dabbiru, Sanjana Roy, Cailin O'Connell, Biana Godin, Shreya A Raghavan, Aparna Kamat> ;ACS Applied Bio Materials. 2024 Apr 1
- 3 citationsThe Proteolytic Landscape of Ovarian Cancer: Applications in Nanomedicine.Cailin O'Connell, Sabrina VandenHeuvel, Aparna Kamat, Shreya Raghavan, Biana Godin> ;International Journal of Molecular Sciences. 2022 Sep 1
- 2 citationsAuthor Correction: Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma.Premal H. Thaker, Liz Y. Han, Aparna A. Kamat, Jesusa M.G. Arevalo, Rie Takahashi, Chunhua Lu, Nicholas B. Jennings, Guillermo N. Armaiz-Pena, James A. Bankson, Murali...> ;Nature Medicine. 2021 Nov 19
- Join now to see all
Press Mentions
The Case for Tumor and Germline Testing in Endometrial Cancer PatientsJune 27th, 2019
BAPS Hosts Inspiring Women’s ConferenceApril 18th, 2019
Professional Memberships
- Fellow
Hospital Affiliations
Houston Methodist HospitalHouston, Texas
Houston Methodist Sugar Land HospitalSugar Land, Texas- Houston Methodist Willowbrook HospitalHouston, Texas
Houston Methodist West HospitalHouston, Texas
